UK Trade and Investment and Integrium Clinical Research are proud to invite you to the:

2015 Medical Technology Seminar
February 24th 2015

Come learn about NHS Market Access, Reimbursement, and the Clinical trial process for medical devices.

Speakers:

• Marg Parton
  UKTI Medical Device Specialist
• Ravi Chana
  Business Development Manager NIHR Office for Clinical Research Infrastructure NOCRI
• Michael Branagan-Harris
  CEO Device Access
• Dr. Joel Neutel
  Founding Partner, Integrium Clinical Research

About the Presenters

Marg Parton OBE

Sector Specialist Medtech and Healthcare, UK Trade and Investment

Marg Parton has a wide experience of building successful partnerships and collaborations in the Life Sciences. She successfully established Southern Bioscience and Southern Medical which brought together industry, academia and clinical teams to focus on key research priorities before joining the DTI to establish and operate the UK/US Bioscience Collaboration focusing on collaborative research in healthcare. She became UKTI’s first International Life Science Champion in 2005.

In 2007 she had the opportunity to establish a new programme for the Department of Health, the NHS Technology Adoption Centre enabling her to gain a unique insight into the adoption and procurement processes within the NHS.

Standing down from NTAC after 3 years she remained engaged with the technology adoption and innovation agendas through her work as Sector Specialist for Healthcare and Medtech for UKTI and Monitoring Liaison Officer for the Technology Strategy Board.

Margaret has a keen interest in the Medtech and Cell Therapy areas and works with both the Cell Therapy Catapult and InnovateUK in driving the thinking around adoption and reimbursement in this emerging area.

Ravi Chana

Ph.D., Counsel, Buchanan Ingersoll & Rooney PC

Ravi is Business Development Manager within the industry team of the NIHR Office for Clinical Research Infrastructure (NOCRI). Ravi’s remit is to facilitate initial engagement between the life sciences industry and NIHR academic investigators, linking them together, to form research collaborations and partnerships He has a particular focus on NIHR medtech and diagnostic research, and has good connections to NIHR investigators/centres that focus on medtech/diagnostic clinical research.

With a degree in Pharmacology, Ravi worked in the healthcare industry for over 15 years undertaking sales, marketing, market access, and business development roles. Prior to joining NOCRI, Ravi headed the Health Economics function within a UK affiliate of a multinational diagnostics company. Ravi has also been part of various working groups within the National Institute of Health and Care Excellence (NICE) and the British In-Vitro Diagnostics Association (BIVDA).

Michael J Branagan-Harris

UK NHS Market Access & Reimbursement Specialist

Chief Executive Officer, Device Access UK Ltd

Michael Branagan-Harris, CEO of Device Access UK Ltd, has been marketing medical devices for over 26 years in the UK, Europe and Asia Pacific regions. During this time he has introduced new technologies into the NHS including VNUS Closure® an innovative treatment for varicose veins, Lap Band® gastric band for obesity surgery, EVT™ endovascular grafts for endovascular aneurysm repair, and other minimally invasive endoscopic and endoluminal devices for general surgery, urology, gynaecology, colorectal, orthopaedic & cardiovascular surgery.

Michael is the CEO of Device Access UK Ltd., the UK’s leading NHS MedTech Market Access consultancy specializing in advising based companies with UK MedTech device market access, pricing & reimbursement and has been instrumental for the success of a number of clients both from Europe and USA.

For his clients he studies HRG/DRG coding & NHS Informatics to identify the most opportune NHS hospitals by diagnosis and intervention. This in turn helps his clients focus on the biggest opportunities for accelerated market entry and or clinical research.

In addition Michael engages regularly with the NHS National Institute for Health & Care Excellence (NICE), and has worked with many of his clients to assist them in the process of the various NICE pathways including Medical Devices Evaluation Programme (MTEP), Interventional Procedures (IP), Diagnostic Advisory Programme (DAP) and Technology Appraisal (TA).

Device Access are able to provide European MedTech Market Access & Reimbursement reports, which have helped many clients decide which markets to concentrate on first along with market specific reimbursement and regulatory information.

Dr. Joel Neutel

Medical Director, Integrium Clinical Research, LLC

Dr. Neutel has had over 25 years of extensive experience serving the biopharmaceutical and medical device industry in the areas of clinical and academic research, as well as strategic planning and market positioning. Dr. Neutel maintains major responsibility as Medical Director at the Orange County Research Center in Orange County, California, where he has served as Study Principal Investigator on many multinational trials

After receiving his medical degree at the University of Witwatersrand in Johannesburg, South Africa, Dr. Neutel completed his internship and residency in internal medicine at the Veterans Administration Medical Center in Long Beach and The University of California, Irvine. He has conducted extensive research in such disciplines as cardiovascular medicine, endocrinology, and central nervous system disorders, with special attention to the pharmacotherapy of the diseases in these areas. Dr. Neutel is designated as a Specialist in Clinical Hypertension by the American Society of Hypertension (ASH).